LGND
Price
$105.99
Change
+$1.81 (+1.74%)
Updated
Jun 6 closing price
Capitalization
2.01B
64 days until earnings call
SAGE
Price
$6.85
Change
+$0.07 (+1.03%)
Updated
Jun 6 closing price
Capitalization
423.63M
58 days until earnings call
Interact to see
Advertisement

LGND vs SAGE

Header iconLGND vs SAGE Comparison
Open Charts LGND vs SAGEBanner chart's image
Ligand Pharmaceuticals
Price$105.99
Change+$1.81 (+1.74%)
Volume$91.81K
Capitalization2.01B
Sage Therapeutics
Price$6.85
Change+$0.07 (+1.03%)
Volume$772.67K
Capitalization423.63M
LGND vs SAGE Comparison Chart
Loading...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGND vs. SAGE commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a Buy and SAGE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (LGND: $100.19 vs. SAGE: $6.48)
Brand notoriety: LGND and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGND: 100% vs. SAGE: 63%
Market capitalization -- LGND: $2.01B vs. SAGE: $423.63M
LGND [@Biotechnology] is valued at $2.01B. SAGE’s [@Biotechnology] market capitalization is $423.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 1 green FA rating(s).

  • LGND’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, SAGE is a better buy in the long-term than LGND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 3 TA indicator(s) are bullish while SAGE’s TA Score has 4 bullish TA indicator(s).

  • LGND’s TA Score: 3 bullish, 7 bearish.
  • SAGE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than LGND.

Price Growth

LGND (@Biotechnology) experienced а -2.21% price change this week, while SAGE (@Biotechnology) price change was -4.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

LGND is expected to report earnings on Aug 11, 2025.

SAGE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($2.01B) has a higher market cap than SAGE($424M). SAGE YTD gains are higher at: 19.337 vs. LGND (-6.496). LGND has higher annual earnings (EBITDA): 40.8M vs. SAGE (-409.48M). SAGE has more cash in the bank: 504M vs. LGND (256M). LGND has less debt than SAGE: LGND (7.11M) vs SAGE (11.8M). LGND has higher revenues than SAGE: LGND (167M) vs SAGE (41.2M).
LGNDSAGELGND / SAGE
Capitalization2.01B424M474%
EBITDA40.8M-409.48M-10%
Gain YTD-6.49619.337-34%
P/E Ratio46.19N/A-
Revenue167M41.2M405%
Total Cash256M504M51%
Total Debt7.11M11.8M60%
FUNDAMENTALS RATINGS
LGND vs SAGE: Fundamental Ratings
LGND
SAGE
OUTLOOK RATING
1..100
6851
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
9198
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
9197
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAGE's Valuation (31) in the Pharmaceuticals Other industry is somewhat better than the same rating for LGND (76) in the Biotechnology industry. This means that SAGE’s stock grew somewhat faster than LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (65) in the Biotechnology industry is somewhat better than the same rating for SAGE (100) in the Pharmaceuticals Other industry. This means that LGND’s stock grew somewhat faster than SAGE’s over the last 12 months.

LGND's SMR Rating (91) in the Biotechnology industry is in the same range as SAGE (98) in the Pharmaceuticals Other industry. This means that LGND’s stock grew similarly to SAGE’s over the last 12 months.

LGND's Price Growth Rating (61) in the Biotechnology industry is in the same range as SAGE (63) in the Pharmaceuticals Other industry. This means that LGND’s stock grew similarly to SAGE’s over the last 12 months.

LGND's P/E Growth Rating (91) in the Biotechnology industry is in the same range as SAGE (97) in the Pharmaceuticals Other industry. This means that LGND’s stock grew similarly to SAGE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LGNDSAGE
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
81%
Momentum
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
76%
MACD
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
76%
Bearish Trend 12 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
71%
Bearish Trend 12 days ago
84%
Advances
ODDS (%)
Bullish Trend 21 days ago
73%
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 18 days ago
75%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
74%
Aroon
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with ACLX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-1.43%
ACLX - LGND
50%
Loosely correlated
-1.29%
ROIV - LGND
50%
Loosely correlated
-1.30%
SYRE - LGND
47%
Loosely correlated
+0.60%
CRNX - LGND
46%
Loosely correlated
+1.39%
KYMR - LGND
46%
Loosely correlated
+2.35%
More

SAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAGE has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SAGE jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAGE
1D Price
Change %
SAGE100%
-0.61%
PHIO - SAGE
41%
Loosely correlated
+16.96%
HRMY - SAGE
40%
Loosely correlated
-0.21%
BPMC - SAGE
38%
Loosely correlated
-4.76%
VERV - SAGE
37%
Loosely correlated
-1.17%
LGND - SAGE
36%
Loosely correlated
-1.43%
More